These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22974281)

  • 21. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.
    Thomson JM; Distler AM; Prati F; Bonomo RA
    J Biol Chem; 2006 Sep; 281(36):26734-44. PubMed ID: 16803899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human metallo-β-lactamase enzymes degrade penicillin.
    Diene SM; Pinault L; Keshri V; Armstrong N; Khelaifia S; Chabrière E; Caetano-Anolles G; Colson P; La Scola B; Rolain JM; Pontarotti P; Raoult D
    Sci Rep; 2019 Aug; 9(1):12173. PubMed ID: 31434986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.
    Kuzin AP; Nukaga M; Nukaga Y; Hujer A; Bonomo RA; Knox JR
    Biochemistry; 2001 Feb; 40(6):1861-6. PubMed ID: 11327849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species.
    Papp-Wallace KM; McLeod SM; Miller AA
    Clin Infect Dis; 2023 May; 76(Suppl 2):S194-S201. PubMed ID: 37125470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.
    Pattanaik P; Bethel CR; Hujer AM; Hujer KM; Distler AM; Taracila M; Anderson VE; Fritsche TR; Jones RN; Pagadala SR; van den Akker F; Buynak JD; Bonomo RA
    J Biol Chem; 2009 Jan; 284(2):945-53. PubMed ID: 18955486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.
    Reynolds KA; Hanes MS; Thomson JM; Antczak AJ; Berger JM; Bonomo RA; Kirsch JF; Handel TM
    J Mol Biol; 2008 Oct; 382(5):1265-75. PubMed ID: 18775544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.
    Che T; Rodkey EA; Bethel CR; Shanmugam S; Ding Z; Pusztai-Carey M; Nottingham M; Chai W; Buynak JD; Bonomo RA; van den Akker F; Carey PR
    Biochemistry; 2015 Jan; 54(3):734-43. PubMed ID: 25536850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why tazobactam and sulbactam have different intermediates population with SHV-1 β-lactamase: a molecular dynamics study.
    Li R; Wang YT; Chen CL
    J Mol Model; 2013 Jun; 19(6):2519-24. PubMed ID: 23455927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.
    McLeod SM; Shapiro AB; Moussa SH; Johnstone M; McLaughlin RE; de Jonge BLM; Miller AA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
    Sun T; Bethel CR; Bonomo RA; Knox JR
    Biochemistry; 2004 Nov; 43(44):14111-7. PubMed ID: 15518561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling.
    Chaibi EB; Péduzzi J; Farzaneh S; Barthélémy M; Sirot D; Labia R
    Biochim Biophys Acta; 1998 Jan; 1382(1):38-46. PubMed ID: 9507060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate.
    Mehta SC; Furey IM; Pemberton OA; Boragine DM; Chen Y; Palzkill T
    J Biol Chem; 2021; 296():100155. PubMed ID: 33273017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor.
    Concha NO; Janson CA; Rowling P; Pearson S; Cheever CA; Clarke BP; Lewis C; Galleni M; Frère JM; Payne DJ; Bateson JH; Abdel-Meguid SS
    Biochemistry; 2000 Apr; 39(15):4288-98. PubMed ID: 10757977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the inhibitor-resistant SHV β-lactamase SHV-107 in a clinical Klebsiella pneumoniae strain coproducing GES-7 enzyme.
    Manageiro V; Ferreira E; Cougnoux A; Albuquerque L; Caniça M; Bonnet R
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1042-6. PubMed ID: 22083476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.
    Rodkey EA; Winkler ML; Bethel CR; Pagadala SR; Buynak JD; Bonomo RA; van den Akker F
    PLoS One; 2014; 9(1):e85892. PubMed ID: 24454944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.
    Ke W; Bethel CR; Thomson JM; Bonomo RA; van den Akker F
    Biochemistry; 2007 May; 46(19):5732-40. PubMed ID: 17441734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A structure-based analysis of the inhibition of class A beta-lactamases by sulbactam.
    Imtiaz U; Billings EM; Knox JR; Mobashery S
    Biochemistry; 1994 May; 33(19):5728-38. PubMed ID: 8180199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.